John P. Brancaccio, Director at SYNERGY PHARMACEUTICALS, INC. (SGYP), bought 6,500 shares at $3.59 ($23K) on 2017-05-26, disclosed to the SEC on 2017-05-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HEPA | BUY | 2020-12-02 | $11K | — | Filing → |
| CRDF | BUY | 2020-05-18 | $10K | — | Filing → |
| TROV | BUY | 2018-06-13 | $8K | — | Filing → |